2017
DOI: 10.3389/fimmu.2017.00622
|View full text |Cite
|
Sign up to set email alerts
|

Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary

Abstract: Human immunodeficiency virus (HIV) infects millions of people worldwide, and new cases continue to emerge. Once infected, the virus cannot be cleared by the immune system and causes acquired immunodeficiency syndrome. Combination antiretroviral therapeutic regimen effectively suppresses viral replication and halts disease progression. The treatment, however, does not eliminate the virus-infected cells, and interruption of treatment inevitably leads to viral rebound. The rebound virus originates from a group of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 161 publications
(229 reference statements)
0
4
0
Order By: Relevance
“…In particular, PD-L1 hi EBV + HL and DLBCL tumor cells may be suitable therapeutic targets for anti-PD-1/PD-L1 immunotherapy with the aim to unleash host antitumor immune responses. Moreover, the recently identified roles of Tfh cells, FDCs, and FRCs as HIV-1 reservoirs or targets, potentially involved in early and late relapse to ART, could provide new prognosis biomarkers and therapeutic targets, including the use of antifibrotic molecules to revert HIV-1-induced damage to lymphoid stromal cell niches, the purging of the FDC reservoir, or the targeting of infected Tfh cells ( 111 ).…”
Section: Discussionmentioning
confidence: 99%
“…In particular, PD-L1 hi EBV + HL and DLBCL tumor cells may be suitable therapeutic targets for anti-PD-1/PD-L1 immunotherapy with the aim to unleash host antitumor immune responses. Moreover, the recently identified roles of Tfh cells, FDCs, and FRCs as HIV-1 reservoirs or targets, potentially involved in early and late relapse to ART, could provide new prognosis biomarkers and therapeutic targets, including the use of antifibrotic molecules to revert HIV-1-induced damage to lymphoid stromal cell niches, the purging of the FDC reservoir, or the targeting of infected Tfh cells ( 111 ).…”
Section: Discussionmentioning
confidence: 99%
“…TFH cells have been demonstrated to be both productively (i.e., vRNA + ) and latently (i.e., vDNA) infected at higher frequencies ( 5 , 56 ) than non-TFH cells. TFH cells are in the vicinity of cells harboring virus-immune complexes like FDCs and B cells ( 57 59 ) that serve as a significant reservoir and are able to effectively infect CD4 + T cells in vitro ( 41 , 60 , 61 ). Their unique localization in combination with their activation status could contribute to the higher infection levels of TFH cells in vivo .…”
Section: Tfh Cells: a Preferential Hiv/siv Reservoirmentioning
confidence: 99%
“…The transcriptional suppressor BCL-6 has been shown to suppress the expression of antiviral genes in TFH cells ( 61 , 72 ). Indeed, several genes are under direct or indirect control of BCL-6 and are positively correlated to the maintenance of HIV reservoir (IntDNA) and to the other viral outcomes (TILDA and VL) (Figure 2 A).…”
Section: Molecular Pathways Promoting Tfh Susceptibility To Hiv Infecmentioning
confidence: 99%
See 1 more Smart Citation